Differential Effects of Sphingolipids on Cell Death and Antioxidant Defenses in Type 1 and Type 2 Endometrial Cancer Cells
- PMID: 40429618
- PMCID: PMC12110862
- DOI: 10.3390/ijms26104472
Differential Effects of Sphingolipids on Cell Death and Antioxidant Defenses in Type 1 and Type 2 Endometrial Cancer Cells
Abstract
Endometrial cancer (EC) is classified into two main subtypes with distinct molecular profiles. Sphingolipids, particularly ceramide and sphingosine-1-phosphate (S1P), are crucial regulators of cell survival, apoptosis, and oxidative stress. This study examined the impact of sphingolipid metabolism in Ishikawa (type 1) and HEC-1A (type 2) EC cells following the silencing of Sptlc1 and Sptlc2, which encode subunits of serine palmitoyltransferase (SPT), a key enzyme in de novo sphingolipid synthesis. Gene silencing was confirmed by RT-PCR and Western blot, while sphingolipid levels were quantified using UHPLC/MS/MS and the sphingolipid rheostat (S1P/ceramide ratio) was calculated. Cell viability (MTT assay), cell death, ROS levels (ELISA), total antioxidant capacity (TAC), catalase and caspase-3 activity, and mitochondrial membrane potential were also assessed. The obtained data showed higher ceramide levels in Ishikawa(CON) cells and higher S1P levels in HEC-1A(CON) cells, resulting in a higher sphingolipid rheostat in HEC-1A cells. SPT knockdown reduced sphingolipid levels, increased cell viability, elevated ROS levels, and decreased cell death, particularly in Ishikawa cells. Furthermore, after gene silencing, these cells exhibited reduced catalase activity and diminished TAC, indicating an impaired redox balance. These findings reveal subtype-specific responses to disrupted sphingolipid synthesis and highlight the importance of sphingolipid homeostasis in the behavior of EC cells.
Keywords: cell death; cell viability; ceramide; endometrial cancer; sphingolipid rheostat; sphingosine-1-phosphate.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures



Similar articles
-
Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.Exp Eye Res. 2021 Jul;208:108623. doi: 10.1016/j.exer.2021.108623. Epub 2021 May 19. Exp Eye Res. 2021. PMID: 34022173
-
The Interplay between Oxidative Stress and Sphingolipid Metabolism in Endometrial Cancer.Int J Mol Sci. 2024 Sep 24;25(19):10243. doi: 10.3390/ijms251910243. Int J Mol Sci. 2024. PMID: 39408574 Free PMC article.
-
Altered sphingolipid metabolism in human endometrial cancer.Prostaglandins Other Lipid Mediat. 2010 Jun;92(1-4):62-6. doi: 10.1016/j.prostaglandins.2010.03.002. Epub 2010 Mar 10. Prostaglandins Other Lipid Mediat. 2010. PMID: 20226264
-
A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.Int J Mol Sci. 2022 Apr 4;23(7):4010. doi: 10.3390/ijms23074010. Int J Mol Sci. 2022. PMID: 35409370 Free PMC article. Review.
-
Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Future Oncol. 2010 Oct;6(10):1603-24. doi: 10.2217/fon.10.116. Future Oncol. 2010. PMID: 21062159 Free PMC article. Review.
References
-
- Hamilton C.A., Cheung M.K., Osann K., Chen L., Teng N.N., Longacre T.A., Powell M.A., Hendrickson M.R., Kapp D.S., Chan J.K. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br. J. Cancer. 2006;94:642–646. doi: 10.1038/sj.bjc.6603012. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials